A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity.

Volume: 11, Issue: 6, Pages: 722 - 733
Published: Jun 1, 2003
Abstract
Objective: To evaluate the efficacy and safety of topiramate (TPM) for weight loss in healthy obese subjects. Research Methods and Procedures: A randomized, double-blind, placebo-controlled, dose-ranging trial was conducted. Three hundred eighty-five subjects, 18 and 75 years of age, were randomized to receive either placebo or TPM at 64, 96, 192, or 384 mg daily. Dosing began at 16 mg once daily. In week 2, the dose was increased to 16 mg...
Paper Details
Title
A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity.
Published Date
Jun 1, 2003
Volume
11
Issue
6
Pages
722 - 733
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.